In patients with malignancies, chronic hepatitis C reactivation or severe flare is uncommon and antiviral treatment is deferred mainly due to underlying bone marrow and immune suppression. We report the use of antiviral treatment concomitantly to chemotherapy in 3 children with hematologic malignancies, chronic hepatitis C, and significant liver dysfunction.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/INF.0b013e3181c2115a | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!